|
Volumn 299, Issue 5612, 2003, Pages 1505-1508
|
Escape artist par excellence
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BIOMEDICAL ENGINEERING;
IMMUNOLOGY;
RESEARCH;
IMMUNE DEFENCES;
DISEASES;
HUMAN IMMUNODEFICIENCY VIRUS VACCINE;
ANTIVIRUS AGENT;
CHEMOKINE;
CHEMOKINE RECEPTOR;
GLYCOPROTEIN GP 120;
HIV ENVELOPE PROTEIN GP120 (305 321);
HIV ENVELOPE PROTEIN GP120 (305-321);
HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;
PEPTIDE FRAGMENT;
VIRUS RECEPTOR;
HUMAN IMMUNODEFICIENCY VIRUS;
IMMUNE SYSTEM;
DRUG DESIGN;
DRUG RESEARCH;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS;
IMMUNE SYSTEM;
IMMUNITY;
MOLECULAR EVOLUTION;
NONHUMAN;
PRIORITY JOURNAL;
SHORT SURVEY;
ANIMAL;
ARTICLE;
CHEMISTRY;
EVOLUTION;
GENETICS;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
IMMUNOLOGY;
INNATE IMMUNITY;
METABOLISM;
MOLECULAR MIMICRY;
MUTATION;
PATHOGENICITY;
PHYSIOLOGY;
PROTEIN CONFORMATION;
SERODIAGNOSIS;
VIROLOGY;
VIRUS CAPSID;
VIRUS REPLICATION;
DARWINIA;
HUMAN IMMUNODEFICIENCY VIRUS;
AIDS VACCINES;
ANIMALS;
ANTIVIRAL AGENTS;
CAPSID;
CHEMOKINES;
EVOLUTION;
HIV;
HIV ANTIBODIES;
HIV ENVELOPE PROTEIN GP120;
HIV INFECTIONS;
HUMANS;
IMMUNITY, NATURAL;
MOLECULAR MIMICRY;
MUTATION;
NEUTRALIZATION TESTS;
PEPTIDE FRAGMENTS;
PROTEIN CONFORMATION;
RECEPTORS, CHEMOKINE;
RECEPTORS, HIV;
VIRUS REPLICATION;
|
EID: 0037423799
PISSN: 00368075
EISSN: None
Source Type: Journal
DOI: 10.1126/science.299.5612.1505 Document Type: Short Survey |
Times cited : (13)
|
References (0)
|